IceCure Medical Ltd
ICCM
$0.9512
$0.00120.13%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -30.28% | 7.90% | 4.65% | 33.65% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -30.28% | 7.90% | 4.65% | 33.65% | |
| Cost of Revenue | -33.24% | -4.37% | 21.54% | 43.51% | |
| Gross Profit | -26.71% | 22.12% | -15.94% | 23.43% | |
| SG&A Expenses | 54.55% | -10.80% | -9.14% | -2.55% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 15.63% | -15.52% | -5.87% | -4.13% | |
| Operating Income | -32.50% | 20.90% | 7.76% | 13.15% | |
| Income Before Tax | -49.55% | 20.78% | 4.22% | 24.22% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -49.55% | 20.78% | 4.22% | 24.22% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -49.55% | 20.78% | 4.22% | 24.22% | |
| EBIT | -32.50% | 20.90% | 7.76% | 13.15% | |
| EBITDA | -33.34% | 21.39% | 8.07% | 13.63% | |
| EPS Basic | -21.95% | 26.17% | 6.54% | 37.58% | |
| Normalized Basic EPS | -21.95% | 26.27% | -- | 37.60% | |
| EPS Diluted | -21.95% | 26.17% | 6.54% | 37.58% | |
| Normalized Diluted EPS | -21.95% | 26.27% | -- | 37.60% | |
| Average Basic Shares Outstanding | 22.62% | 7.33% | 2.44% | 21.45% | |
| Average Diluted Shares Outstanding | 22.62% | 7.33% | 2.44% | 21.45% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |